Biotech

All Articles

Praxis epilepsy drug decreases seizures in phase 2 litigation

.Practice Preciseness Medicines has racked up yet another midphase succeed in epilepsy this year, al...

Three officers surrender as Dyne messages combined records for DMD prospect

.After getting away from a medical hold a number of years back, Dyne Therapy has actually exposed br...

Arrowhead fires off stage 3 data in uncommon metabolic illness ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own give in advance of a possible showdown with...

Pfizer, Valneva present lyme health condition shot successful for 2nd enhancer

.Pfizer and also Valneva may possess regarding two more years to wait just before they produce the 1...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's study a talk with Ayla Ellison, Strong Biotech Managing Editor and also Michelle Benz as they...

New information show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the phase 3 test for its variable XIa inhibitor asundexian late in 2014 after the m...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stockpile as fund presents intent to form its development

.Galapagos is actually coming under extra stress from clients. Having actually built a 9.9% risk in ...

Cell- focused Sana scoops first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, firings ...

Allist settles Jacobio $21M, landing role in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has actually purchased itself a starring job in China's KRAS market...